galactosylceramidase-transferrin receptor antibody fusion protein (JCR Pharmaceuticals)

N/A

Report date: 2025/03/20 15:49:26

Base Information

Drug Namegalactosylceramidase-transferrin receptor antibody fusion protein (JCR Pharmaceuticals)
Drug Alias Nametransferrin receptor-targeted GALC (JCR Pharmaceuticals)
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGalactocerebrosidase modulatorsTransferrin receptors modulators
TargetsGalactocerebrosidaseTransferrin receptors
Therapy Area/IndicationsLeukodystrophy, Globoid Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJcr Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJcr Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukodystrophy, Globoid Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A